Präsentiert durch Paradigm Publishing Services
Columbia University Press
Kapitel
Lizenziert
Nicht lizenziert
Erfordert eine Authentifizierung
6. LENGTHENING AND SHORTENING A PATENT’S TERM
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Kapitel in diesem Buch
- Frontmatter i
- CONTENTS v
- PREFACE xiii
- INTRODUCTION 1
-
SECTION I: PATENT LAW
- 1. THE PATENT AS A NEGATIVE RIGHT AND THE CLAIM AS ITS BUSINESS END 13
- 2. CONSTRUING THE PATENT CLAIM 24
- 3. THE PATENTABLE INVENTION 29
- 4. THE PATENT DOCUMENT’S ROLE IN SUPPORTING A CLAIMED INVENTION 49
- 5. THE LONG ROAD TO GETTING A PATENT 57
- 6. LENGTHENING AND SHORTENING A PATENT’S TERM 70
- 7. CONTINUING-APPLICATION PRACTICE AND THE MAKING OF A PATENT FAMILY 78
- 8. THE MURKY WORLD OF INVENTORSHIP 89
- 9. PATENT INFRINGEMENT AND ITS VARIATIONS 101
- 10. DEFENSES AND PREEMPTIVE CHALLENGES 116
- 11. PATENT OPINIONS 129
- 13. THE INTERPLAY BETWEEN TRADE SECRETS AND PATENTS 151
-
SECTION II: REGULATORY LAW
- 14. THE INNOVATOR DRUG: FROM DEVELOPMENT TO APPROVAL 163
- 15. GENERIC DRUGS 180
- 16. BIOSIMILARS 207
-
SECTION III: CONTRACT LAW
- 17. THE CONTRACT: AN ENFORCEABLE PROMISE 225
- 18. BIOTECHNOLOGY AGREEMENTS 242
- ACKNOWLEDGMENTS 283
- FURTHER READING 285
- GLOSSARY OF LEGAL ACRONYMS AND ABBREVIATIONS 295
- INDEX 297
Kapitel in diesem Buch
- Frontmatter i
- CONTENTS v
- PREFACE xiii
- INTRODUCTION 1
-
SECTION I: PATENT LAW
- 1. THE PATENT AS A NEGATIVE RIGHT AND THE CLAIM AS ITS BUSINESS END 13
- 2. CONSTRUING THE PATENT CLAIM 24
- 3. THE PATENTABLE INVENTION 29
- 4. THE PATENT DOCUMENT’S ROLE IN SUPPORTING A CLAIMED INVENTION 49
- 5. THE LONG ROAD TO GETTING A PATENT 57
- 6. LENGTHENING AND SHORTENING A PATENT’S TERM 70
- 7. CONTINUING-APPLICATION PRACTICE AND THE MAKING OF A PATENT FAMILY 78
- 8. THE MURKY WORLD OF INVENTORSHIP 89
- 9. PATENT INFRINGEMENT AND ITS VARIATIONS 101
- 10. DEFENSES AND PREEMPTIVE CHALLENGES 116
- 11. PATENT OPINIONS 129
- 13. THE INTERPLAY BETWEEN TRADE SECRETS AND PATENTS 151
-
SECTION II: REGULATORY LAW
- 14. THE INNOVATOR DRUG: FROM DEVELOPMENT TO APPROVAL 163
- 15. GENERIC DRUGS 180
- 16. BIOSIMILARS 207
-
SECTION III: CONTRACT LAW
- 17. THE CONTRACT: AN ENFORCEABLE PROMISE 225
- 18. BIOTECHNOLOGY AGREEMENTS 242
- ACKNOWLEDGMENTS 283
- FURTHER READING 285
- GLOSSARY OF LEGAL ACRONYMS AND ABBREVIATIONS 295
- INDEX 297